Top 10: upregulated genes placebo versus TIFN101 |
Immunoglobulin lambda variable 6–57 |
IGLV6-57 |
0.01 |
1.63 |
Putative V-set and immunoglobulin domain-containing protein 6-like |
LOC642131 |
0.00 |
1.55 |
Immunoglobulin lambda variable 7–46 (gene/pseudogene) |
IGLV7-46 |
0.04 |
1.48 |
Heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1 |
HS3ST3B1 |
0.00 |
1.41 |
Interferon regulatory factor 4 |
IRF4 |
0.00 |
1.40 |
GDNF family receptor alpha 2 |
GFRA2 |
0.00 |
1.40 |
CD27 molecule |
CD27 |
0.01 |
1.40 |
CD79a molecule, immunoglobulin-associated alpha |
CD79A |
0.03 |
1.38 |
Plasminogen activator, tissue |
PLAT |
0.00 |
1.37 |
Der1-like domain family, member 3 |
DERL3 |
0.00 |
1.37 |
Top 10: downregulated genes placebo versus TIFN101 |
Small nucleolar RNA, H/ACA box 38B (retrotransposed) |
SNORA38B |
0.04 |
−1.40 |
Small nucleolar RNA, H/ACA box 21 |
SNORA21 |
0.03 |
−1.40 |
Small nucleolar RNA, H/ACA box 60 |
SNORA60 |
0.01 |
−1.41 |
Small nucleolar RNA, C/D box 53 |
SNORD53 |
0.01 |
−1.43 |
Ephrin-A1 |
EFNA1 |
0.00 |
−1.45 |
Small nucleolar RNA, C/D box 6 |
SNORD6 |
0.02 |
−1.46 |
Small nucleolar RNA, H/ACA box 57 |
SNORA57 |
0.00 |
−1.47 |
Small nucleolar RNA, H/ACA box 14B |
SNORA14B |
0.00 |
−1.73 |
Family with sequence similarity 5, member C |
FAM5C |
0.03 |
−1.97 |
Small Cajal body-specific RNA 4 |
SCARNA4 |
0.00 |
−2.00 |